Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group.
J Rheumatol
; 33(7): 1403-8, 2006 Jul.
Article
in En
| MEDLINE
| ID: mdl-16724374
ABSTRACT
The International COX-2 Study Group, a panel of independent physicians and scientists, convened January 28-30, 2005, in Washington, DC, to discuss the issues concerning the cardiovascular (CV) profile of coxibs. The purpose of the meeting was to review potential mechanisms by which inhibition of COX-2 by selective and nonselective NSAID could increase risk of CV events, to evaluate the similarities and differences between drugs based on mechanism and pharmacology, and to propose potential trial methodology to more definitively answer questions regarding cardiovascular risk.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Cardiovascular Diseases
/
Cyclooxygenase 2 Inhibitors
/
Membrane Proteins
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
J Rheumatol
Year:
2006
Document type:
Article
Affiliation country:
Estados Unidos